Chesley Taft & Associates LLC Stryker Corp Transaction History

Chesley Taft & Associates LLC

$2.08 Billion
Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Stryker Corp stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 147,881 shares of SYK stock, worth $54.8 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

147,881

Previous 150,627 1.82%

Holding current value

$54.8 Million

Previous $51.3 Million 4.23%

% of portfolio

2.57%

Previous 2.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$315.94 - $371.96 $867,571 - $1.02 Million	-2,746 Reduced 1.82%	147,881 $53.4 Million
Q2 2024 Jul 19, 2024	BUY	$324.3 - $354.67 $318,786 - $348,640	983 Added 0.66%	150,627 $51.3 Million
Q1 2024 Apr 15, 2024	SELL	$293.94 - $358.71 $275,421 - $336,111	-937 Reduced 0.62%	149,644 $53.6 Million
Q4 2023 Jan 11, 2024	BUY	$253.85 - $299.46 $1.08 Million - $1.28 Million	4,270 Added 2.92%	150,581 $45.1 Million
Q3 2023 Oct 10, 2023	SELL	$266.54 - $302.43 $231,889 - $263,114	-870 Reduced 0.59%	146,311 $40 Million
Q2 2023 Jul 17, 2023	SELL	$271.49 - $305.09 $547,052 - $614,756	-2,015 Reduced 1.35%	147,181 $44.9 Million
Q1 2023 Apr 11, 2023	SELL	$246.13 - $285.47 $220,286 - $255,495	-895 Reduced 0.6%	149,196 $42.6 Million
Q4 2022 Jan 19, 2023	SELL	$205.51 - $253.93 $31,032 - $38,343	-151 Reduced 0.1%	150,091 $0
Q3 2022 Oct 13, 2022	SELL	$189.27 - $231.83 $348,446 - $426,799	-1,841 Reduced 1.21%	150,242 $30.4 Million
Q2 2022 Jul 07, 2022	SELL	$194.09 - $276.37 $179,533 - $255,642	-925 Reduced 0.6%	152,083 $30.3 Million
Q1 2022 Apr 14, 2022	SELL	$245.33 - $277.77 $1.63 Million - $1.85 Million	-6,654 Reduced 4.17%	153,008 $40.2 Million
Q4 2021 Jan 05, 2022	SELL	$236.63 - $276.44 $433,269 - $506,161	-1,831 Reduced 1.13%	159,662 $42.7 Million
Q3 2021 Oct 05, 2021	SELL	$248.9 - $280.09 $136,148 - $153,209	-547 Reduced 0.34%	161,493 $42.6 Million
Q2 2021 Jul 07, 2021	SELL	$242.95 - $267.0 $374,385 - $411,447	-1,541 Reduced 0.94%	162,040 $42.1 Million
Q1 2021 Apr 06, 2021	SELL	$221.01 - $248.82 $356,931 - $401,844	-1,615 Reduced 0.98%	163,581 $40.6 Million
Q4 2020 Jan 11, 2021	SELL	$202.01 - $245.04 $262,208 - $318,061	-1,298 Reduced 0.78%	165,196 $40.5 Million
Q3 2020 Oct 08, 2020	SELL	$177.77 - $215.81 $366,028 - $444,352	-2,059 Reduced 1.22%	166,494 $34.7 Million
Q2 2020 Jul 08, 2020	SELL	$144.67 - $207.03 $146,984 - $210,342	-1,016 Reduced 0.6%	168,553 $30.4 Million
Q1 2020 Apr 15, 2020	SELL	$126.5 - $225.1 $355,465 - $632,531	-2,810 Reduced 1.63%	169,569 $28.2 Million
Q4 2019 Jan 10, 2020	BUY	$197.98 - $220.53 $987,524 - $1.1 Million	4,988 Added 2.98%	172,379 $36.2 Million
Q3 2019 Oct 07, 2019	SELL	$205.4 - $221.82 $506,721 - $547,229	-2,467 Reduced 1.45%	167,391 $36.2 Million
Q2 2019 Jul 10, 2019	BUY	$180.24 - $205.58 $48,124 - $54,889	267 Added 0.16%	169,858 $34.9 Million
Q1 2019 Apr 05, 2019	BUY	$152.46 - $198.0 $8.97 Million - $11.6 Million	58,815 Added 53.09%	169,591 $33.5 Million
Q4 2018 Jan 07, 2019	SELL	$145.0 - $178.65 $16,095 - $19,830	-111 Reduced 0.1%	110,776 $17.4 Million
Q3 2018 Oct 12, 2018	SELL	$163.25 - $177.68 $169,616 - $184,609	-1,039 Reduced 0.93%	110,887 $19.7 Million
Q2 2018 Jul 12, 2018	SELL	$155.17 - $179.78 $109,394 - $126,744	-705 Reduced 0.63%	111,926 $18.9 Million
Q1 2018 Apr 11, 2018	SELL	$148.01 - $168.91 $268,638 - $306,571	-1,815 Reduced 1.59%	112,631 $18.1 Million
Q4 2017 Jan 10, 2018	SELL	$143.51 - $159.74 $218,852 - $243,603	-1,525 Reduced 1.31%	114,446 $17.7 Million
Q3 2017 Oct 13, 2017	BUY	$138.36 - $147.87 $16 Million - $17.1 Million	115,971	115,971 $16.5 Million

Others Institutions Holding SYK

# of Institutions

2,231

Shares Held

284M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $140B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Account

Chesley Taft & Associates LLC Stryker Corp Transaction History